Huang Lei, Wang Xianghong, Zhang Xianxu, Li Shicheng, Liu Xin, Ma Zhong, Qian Bin, Zhou Changlin, Luo Zhiqiang
Department of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Department of Orthopaedics, Gansu Jiuquan Hospital of Traditional Chinese Medicine, Jiuquan, Gansu, China.
PLoS One. 2025 Aug 8;20(8):e0329062. doi: 10.1371/journal.pone.0329062. eCollection 2025.
This study investigates the relationship between smoking and total BMD and examines the mediating role of inflammatory markers in this relationship.
In total, 22,022 participants were included in this study, based on data from the National Health and Nutrition Examination Survey for the periods 2001-2006 and 2011-2018. Weighted linear regression models and restricted cubic splines(RCS) were leveraged to examine the linear or nonlinear relationship between serum cotinine levels and total BMD. Additionally, mediation analysis was leveraged to appraise the potential mediating effects of inflammatory markers, such as lymphocytes, monocytes, neutrophils, and platelets, in the relationship between cotinine and total BMD.
After fully adjusting for all covariates, an increase of one unit in cotinine corresponded to a 0.00022 g/cm2 decrease in total BMD (Beta = -0.00022, 95% CI: -0.0003 ~ -0.0000, P = 0.0069). The RCS analysis indicated an "n-shaped" relationship between cotinine and total BMD (P-nonlinear = 0.0069). According to the mediation analysis, monocytes and neutrophils acted as mediators in the relationship between cotinine and total BMD, with mediation effects accounting for 19.8% and 19.6%, respectively.
Smoking serves as a risk factor for reduced BMD, and the impact on BMD is partially mediated by inflammatory markers such as monocytes and neutrophils. Platelets can moderate the effect of cotinine on total BMD to some extent.
本研究调查吸烟与总骨密度之间的关系,并检验炎症标志物在这种关系中的中介作用。
基于2001 - 2006年和2011 - 2018年国家健康与营养检查调查的数据,本研究共纳入了22,022名参与者。采用加权线性回归模型和受限立方样条(RCS)来检验血清可替宁水平与总骨密度之间的线性或非线性关系。此外,利用中介分析来评估淋巴细胞、单核细胞、中性粒细胞和血小板等炎症标志物在可替宁与总骨密度关系中的潜在中介作用。
在对所有协变量进行充分调整后,可替宁每增加一个单位,总骨密度相应降低0.00022 g/cm²(β = -0.00022,95%置信区间:-0.0003 ~ -0.0000,P = 0.0069)。RCS分析表明可替宁与总骨密度之间呈“n形”关系(P非线性 = 0.0069)。根据中介分析,单核细胞和中性粒细胞在可替宁与总骨密度的关系中起中介作用,中介效应分别占19.8%和19.6%。
吸烟是骨密度降低的一个危险因素,对骨密度的影响部分由单核细胞和中性粒细胞等炎症标志物介导。血小板可在一定程度上调节可替宁对总骨密度的影响。